Peter Rosenthal

Title: The Innovations of Peter Rosenthal

Introduction

Peter Rosenthal is a notable inventor based in Luedenscheid, Germany. He has made significant contributions to the field of molecular medicine, particularly in the development of peptides with specific binding affinities. His work has implications for understanding and treating various medical conditions.

Latest Patents

Peter Rosenthal holds 2 patents. His latest patents focus on peptides that have a binding affinity to antibodies recognizing specific epitopes on adrenoreceptors. These peptides are designed to have an effective dose (ED) of less than 500 nm, particularly around 10 nM. The binding of these antibodies to the epitopes can lead to increased γ-secretase activity, enhanced release of β-amyloid molecules, and potential cellular dysfunction in cerebral blood vessel cells, glial cells, or neurons. The effectiveness of these peptides is measured through bioassays.

Career Highlights

Throughout his career, Peter Rosenthal has worked with prominent organizations such as the Max Delbrück Center for Molecular Medicine in Berlin-Buch and Fresenius Medical Care Deutschland GmbH. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Peter has collaborated with esteemed colleagues, including Rudolf Kunze and Gerd Wallukat. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Peter Rosenthal's work in peptide development showcases his commitment to advancing medical science. His patents and collaborations reflect his significant contributions to the field, making him a noteworthy figure in molecular medicine.